Jane Street’s Opus Genetics IRD Stock Holding History

Jane Street’s Portfolio IRD Stock Details IRD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$84.7K	Sell	20,600 -22,800	-53%	-$106K	﹤0.01%	10687
2026 Q1	$197K	Buy	+43,400	New	+$150K	﹤0.01%	10165

Other funds holding IRD

Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

BCM

BIOS Capital Management Fort Worth, Texas $41.7M AUM 34.92% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

BCM

Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return

TECP

Trails Edge Capital Partners Atlanta, Georgia $630M AUM

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Jane Street's IRD Position: Q2 2026 in Review

Jane Street increased its Opus Genetics (IRD) stake by 20% in Q2 2026, buying an estimated $144K and bringing the position to 188,988 shares worth $777K. The position accounts for ﹤0.01% of the portfolio, ranked #7070.

Jane Street first reported a position in IRD in Q2 2018 and has held it in 8 quarters since. 103 funds tracked by Wall St. Rank hold IRD as of Q2 2026.

Jane Street held 188,988 shares of Opus Genetics worth $777K as of Q2 2026.
Jane Street bought 30,885 Opus Genetics shares in Q2 2026, an estimated $144K.
Opus Genetics made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #7070 holding.
Jane Street first reported a position in Opus Genetics in Q2 2018 and has held it in 8 quarters since.
103 funds tracked by Wall St. Rank held Opus Genetics as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.